FDA Blood Products Panel
This article was originally published in The Gray Sheet
Executive SummaryConvening Oct. 20 and 21 in Silver Spring, Maryland. On Oct. 20, the panel will discuss "revised donor testing and suitability criteria" for "treponemal screening tests for syphilis," donor suitability, and dating periods for irradiated red blood cells. On Oct. 21, the panel will discuss "public health issues related to the use of gloves by phlebotomists in blood establishments." For information, call Linda Smallwood at 310/594-6700
You may also be interested in...ï»¿
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.